Alison
Dennis provides intellectual property,
commercial and expert regulatory advice to clients in the
pharmaceutical, biotech and medical device industries at all stages
during the life cycle of their products.
Alison has extensive experience of drafting and negotiating a
wide range of specialist agreements for clients in the life sciences sector
including strategic alliances, collaborations, clinical trial
agreements, technical/quality agreements, tolling, manufacturing,
and supply agreements. Alison’s practice also includes advising on
the protection and exploitation of intellectual property rights
through a variety of different structures, where clients have
confirmed that Alison “does a great job” (The Legal
500, 2008).
Alison’s experience includes advising on a wide range of
regulatory issues arising in the pharmaceutical, biotech and
medical device industries. These include complex issues arising in
connection with compliance with the various codes of practice on
advertising and promoting pharmaceuticals and medical devices,
establishment in the EU, the regulation of clinical trials, the
regulation of human tissue use, and dealings with the Medicines and
Healthcare products Regulatory Agency (MHRA) and the European
Medicines Agency (EMEA).
Alison is a regular speaker at international conferences on
compliance issues affecting the pharmaceutical and medical devices
industries.
Alison sits on the Legal Committee and the Compliance Working
Group of the ABHI (UK trade association for medical devices
industry).
Alison regularly
lectures at the University of Cambridge as part of its Masters
of Bioscience Enterprise on life sciences law.
Alison speaks English and French (fluent).